Brinckerhoff Quoted on Patent Trolling in Biopharma

24 July 2013 Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology

Washington, D.C. Partner Courtenay Brinckerhoff was quoted in an article published in Genetic Engineering and Biotechnology News on July 24, 2013 titled “New Gene Patent Suit Sparks Talk of Trolls.” The article discusses a lawsuit issued by Myriad Genetics and whether or not it means patent trolling has come to biopharma. Ms. Brinckerhoff was quoted saying, “Before biotech companies decide to go into the market, they might be more cognizant or concerned about whether they have time to operate, because they’re going to invest a lot of time and money to get there.”

Related Services

Insights

Supreme Court Limits Patent Assignor Estoppel
02 August 2021
PharmaPatents
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream